An interventional study of Collagen Paste and Mucosal advancement in Fistula-in-ano, sponsored by Chinese University of Hong Kong. Recruiting at 2 sites in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-26.
Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment
The treatment for fistula-in-ano (FIA) remains a challenge to General and Colorectal Surgeons Worldwide. A variety of surgical treatments have been described for high anal fistulas, but none offers the panacea of fistula eradication with guaranteed preservation of continence. This study compares Collagen paste injection to mucosal advancement flap for the treatment of fistula-in-ano.
Rectal advancement flaps have been advocated as a means of closing high fistulas with preservation of the external sphincter muscle. With this technique, it shows promising results with success rate of approximately 60%. However, complications have been reported, in particular with a change of continence in 30-35% of patients.
Collagen paste is a novel sphincter-preserving method for fistula closure. Permacol (Medtronic, USA) is a sterile acellular cross-linked porcine dermal collagen matrix suspension. The paste-like suspension form a matrix that accelerates neovascularization, cellular infiltration which promotes healing and fistula closure. The theoretical benefits of paste form compared to previous collagen plug design is that the collagen can moulded into the fistula cavity or tract. This allows better tissue contact with the collagen thus improves healing and reduces the chance of dislodgement. Limited data is available to date. Success rates of collagen paste range from 47.6% to 63%. Hence it has a potential to be the first-line treatment for high FIA with low complication rates and without causing disruption to the anal sphincter complex.
731 studies on the registry are indexed under Fistula; 103 are open to participants now.
This study's planned enrollment of 118 is above the median of 60 across 484 interventional studies indexed under Fistula.
Browse Fistula studies →Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Seton is removed, the fistula tract is de-epithelialised and collagen paste applied.
Procedure: Collagen Paste
The internal opening is excised and is covered with a "U-shape" rectal mucosal flap
Procedure: Mucosal advancement
Collagen paste injection
Mucosal advancement flap
Clinical healing of Fistula-in-ano
Clinical healing of the fistula-in-ano
Time frame: 1 year
30-day morbidity
30-day morbidity using Clavien-Dindo classification
Time frame: 30 days
Quality of life score
Assess effect on Quality of life post operatively using Short Form 36 Health Survey
Time frame: 1 year
Postoperative pain score
assessment of postoperative pain using visual analog score from 0 (no pain) to 10 (severe pain)
Time frame: 1 week
Faecal incontinence rate
Assess postoperative effect on continence
Time frame: 1 year
Hospital readmission rate
Assess hospital re-admission rate
Time frame: 1 year
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese University of Hong Kong